A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 152 participants.
Also called NCT07064486
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 152 participants
- Registry
-
NCT07064486
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Indonesia
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07064486. Randomized; no masking; primary purpose treatment. Start 2025-07-04 (actual); primary completion 2027-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
- Condition
- Type 2 Diabetes (T2DM)
- Intervention (Drug)
- BGM0504
- Intervention (Drug)
- BGM0504
- Intervention (Drug)
- Semaglutide
- Lead sponsor
- BrightGene Bio-Medical Technology Co., Ltd.
Record details
- Record id
cardio:ct-nct07064486- Content hash
5490f59f5a35fde62b545110f48745a1562b85f8570fdc1a3fcadb2060fe14a6